Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Locally Recurrent Head and Neck Squamous Cell Carcinoma · Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma · Locally Recurrent Laryngeal Squamous Cell Carcinoma · Locally Recurrent Oral Cavity Squamous Cell Carcinoma · Locally Recurrent Oropharyngeal Squamous Cell Carcinoma · Stage II Laryngeal Cancer AJCC v8 · Stage II Lip and Oral Cavity Cancer AJCC v8 · Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage III Laryngeal Cancer AJCC v8 · Stage III Lip and Oral Cavity Cancer AJCC v8 · Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IVA Laryngeal Cancer AJCC v8 · Stage IVA Lip and Oral Cavity Cancer AJCC v8 · Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IVB Laryngeal Cancer AJCC v8 · Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Ricklie A. Julian)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Ricklie A. Julian)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Jacob S. Thomas)
  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Christopher U. Jones)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Andrew C. Birkeland)
  • Emory Proton Therapy Center, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · allyson.anderson@emory.edu · 404-251-2854
    Contact: Principal Investigator (Jennifer Gross)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Jennifer Gross)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Jochen H. Lorch)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer_Studies@rush.edu · 312-226-2371
    Contact: Principal Investigator (Michael J. Jelinek)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (Jochen H. Lorch)
  • Rush MD Anderson Cancer Center at Rush Lisle, Lisle, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer_Studies@rush.edu · 312-226-2371
    Contact: Principal Investigator (Michael J. Jelinek)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Jochen H. Lorch)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Jochen H. Lorch)
  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Brendan J. Knapp)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Jochen H. Lorch)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States

  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Omar A. Karadaghy)
  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Omar A. Karadaghy)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Omar A. Karadaghy)
  • LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Sagar G. Kansara)
  • Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Sagar G. Kansara)
  • Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 800-987-3005
    Contact: Principal Investigator (Sarah J. Sinclair)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Paul L. Swiecicki)
  • University of Michigan - Brighton Center for Specialty Care, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 800-865-1125
    Contact: Principal Investigator (Paul L. Swiecicki)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Samantha H. Tam)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brendan J. Knapp)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brendan J. Knapp)
  • University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 913-588-3671
    Contact: Principal Investigator (Omar A. Karadaghy)
  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Omar A. Karadaghy)
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Omar A. Karadaghy)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brendan J. Knapp)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brendan J. Knapp)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Brendan J. Knapp)
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-334-4773
    Contact: Principal Investigator (Yungpo B. Su)
  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Yungpo B. Su)
  • Cooper Hospital University Medical Center, Camden, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 856-325-6757
    Contact: Principal Investigator (Brian Swendseid)
  • Jersey City Medical Center, Jersey City, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Dylan F. Roden)
  • Saint Barnabas Medical Center, Livingston, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · joanne.loeb@rwjbh.org · 973-322-2934
    Contact: Principal Investigator (Dylan F. Roden)
  • Monmouth Medical Center, Long Branch, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Dylan F. Roden)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Dylan F. Roden)
  • Rutgers New Jersey Medical School, Newark, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Dylan F. Roden)
  • Community Medical Center, Toms River, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Lennette.Gonzales@rwjbh.org · 732-557-8294
    Contact: Principal Investigator (Dylan F. Roden)
  • Stony Brook University Medical Center, Stony Brook, New York, United States

    Contact: Study coordinator (Site Public Contact) · 800-862-2215
    Contact: Principal Investigator (Achuta K. Guddati)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Mihir R. Patel)
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Matthew C. Ward)
  • ProMedica Flower Hospital, Sylvania, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · PCIOncResearch@promedica.org · 419-824-1842
    Contact: Principal Investigator (Chang Xia)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Christina Henson)
  • Clackamas Radiation Oncology Center, Clackamas, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Legacy Mount Hood Medical Center, Gresham, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · 503-413-2150
    Contact: Principal Investigator (Andrew Y. Kee)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · cancer@lhs.org · 800-220-4937
    Contact: Principal Investigator (Andrew Y. Kee)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Legacy Meridian Park Hospital, Tualatin, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · 503-413-1742
    Contact: Principal Investigator (Andrew Y. Kee)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Steven B. Chinn)
  • Saint Vincent Hospital, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-452-5000
    Contact: Principal Investigator (Larisa Greenberg)
  • UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Steven B. Chinn)
  • IRMC Cancer Center, Indiana, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Steven B. Chinn)
  • Jefferson Hospital, Jefferson Hills, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ddefazio@wpahs.org · 412-359-3043
    Contact: Principal Investigator (Larisa Greenberg)
  • UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-534-4724
    Contact: Principal Investigator (Steven B. Chinn)
  • Forbes Hospital, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-858-7746
    Contact: Principal Investigator (Larisa Greenberg)
  • UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Steven B. Chinn)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Steven B. Chinn)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jennifer M. Johnson)
  • Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 877-284-2000
    Contact: Principal Investigator (Larisa Greenberg)
  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Steven B. Chinn)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Steven B. Chinn)
  • UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-621-2334
    Contact: Principal Investigator (Steven B. Chinn)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Steven B. Chinn)
  • UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 814-676-7900
    Contact: Principal Investigator (Steven B. Chinn)
  • UPMC Cancer Center-Washington, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Steven B. Chinn)
  • UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · cancer@washingtonhospital.org · 724-223-3788
    Contact: Principal Investigator (Steven B. Chinn)
  • Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Dawnmarie.DeFazio@ahn.org
    Contact: Principal Investigator (Larisa Greenberg)
  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Jennifer M. Johnson)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Alexandra E. Kejner)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Jennifer H. Choe)
  • Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington, United States

    Contact: Study coordinator (Site Public Contact) · oncologyresearch@lhs.org
    Contact: Principal Investigator (Andrew Y. Kee)
  • Legacy Salmon Creek Hospital, Vancouver, Washington, United States

    Contact: Study coordinator (Site Public Contact) · 503-413-2150
    Contact: Principal Investigator (Andrew Y. Kee)
  • University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Justine Yang-Bruce)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Justine Yang-Bruce)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Justine Yang-Bruce)
  • Froedtert Menomonee Falls Hospital, Menomonee Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-257-5100
    Contact: Principal Investigator (Jennifer D. Bruening)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Jennifer D. Bruening)
  • Froedtert and MCW Moorland Reserve Health Center, New Berlin, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Jennifer D. Bruening)
  • Drexel Town Square Health Center, Oak Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Jennifer D. Bruening)
  • Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-0505
    Contact: Principal Investigator (Jennifer D. Bruening)
מובילי המחקר
  • Nabil F Saba

    Principal Investigator

    NRG Oncology